These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2821897)

  • 1. Protection against herpes simplex virus infection in mice by recombinant murine interferon-beta in combination with antibody.
    Kumano Y; Yamamoto M; Mori R
    Antiviral Res; 1987 Jun; 7(5):289-301. PubMed ID: 2821897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.
    Yamamoto M; Hayashi Y; Tang LL; Mori R
    Antiviral Res; 1985 Apr; 5(2):83-91. PubMed ID: 2990334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of monoclonal antibody to herpes simplex virus glycoprotein gB to promote healing of herpetic skin lesions in nude mice.
    Yamamoto M; Tang JL; Kumano Y; Mori R; Kino Y
    Antiviral Res; 1986 Jul; 6(4):223-31. PubMed ID: 3017202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody.
    Hayashida I; Nagafuchi S; Hayashi Y; Kino Y; Mori R; Oda H; Ohtomo N; Tashiro A
    Microbiol Immunol; 1982; 26(6):497-509. PubMed ID: 6290850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant mouse interferon-beta on acute and latent herpes simplex infection in mice.
    Yamada M; Arao Y; Hatano A; Uno F; Nii S
    Arch Virol; 1988; 99(1-2):101-9. PubMed ID: 3355371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).
    Minagawa H; Sakuma S; Mohri S; Mori R; Watanabe T
    Arch Virol; 1988; 103(1-2):73-82. PubMed ID: 2850780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
    J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
    Hayashi K; Hayashi T; Miyazawa K; Tomoda A
    J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
    Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
    Kohl S
    J Immunol; 1990 Jan; 144(1):307-12. PubMed ID: 2153165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin.
    Erlich KS; Dix RD; Mills J
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1006-9. PubMed ID: 2821882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1.
    Rossol-Voth R; Rossol S; Schütt KH; Corridori S; de Cian W; Falke D
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():143-7. PubMed ID: 1703559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection.
    Kino Y; Hayashi Y; Hayashida I; Mori R
    J Gen Virol; 1982 Dec; 63(2):475-9. PubMed ID: 6296289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of the cornea post-infection with plasmid DNA encoding interferon-alpha1 but not recombinant interferon-alphaA reduces herpes simplex virus type 1-induced mortality in mice.
    Noisakran S; Carr DJ
    J Neuroimmunol; 2001 Dec; 121(1-2):49-58. PubMed ID: 11730939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunotherapy for encephalitis caused by herpes simplex virus.
    Erlich KS; Mills J
    Rev Infect Dis; 1986; 8 Suppl 4():S439-45. PubMed ID: 3018895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
    Lobe DC; Spector T; Ellis MN
    Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.